loading

Rani Therapeutics Holdings Inc Borsa (RANI) Ultime notizie

pulisher
Feb 12, 2026

Published on: 2026-02-13 18:32:35 - baoquankhu1.vn

Feb 12, 2026
pulisher
Feb 10, 2026

Is Rani Therapeutics Holdings Inc. stock near bottom after decline2025 Year in Review & Consistent Growth Equity Picks - mfd.ru

Feb 10, 2026
pulisher
Feb 06, 2026

Rani Therapeutics Holdings Inc. (RANI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Feb 06, 2026
pulisher
Feb 02, 2026

Income Plays: What is the next catalyst for Rani Therapeutics Holdings IncWeekly Trade Review & Technical Buy Zone Confirmation - baoquankhu1.vn

Feb 02, 2026
pulisher
Feb 01, 2026

Published on: 2026-02-02 11:44:32 - baoquankhu1.vn

Feb 01, 2026
pulisher
Feb 01, 2026

What is the next catalyst for Rani Therapeutics Holdings IncWeekly Trade Review & Technical Buy Zone Confirmation - baoquankhu1.vn

Feb 01, 2026
pulisher
Jan 31, 2026

Insider Buyers At Rani Therapeutics Holdings Sitting On US$1.3m Profit - simplywall.st

Jan 31, 2026
pulisher
Jan 28, 2026

Rani Therapeutics promotes Alireza Javadi to chief technical officer By Investing.com - Investing.com South Africa

Jan 28, 2026
pulisher
Jan 28, 2026

Rani Therapeutics Holdings, Inc. Announces Promotion of Alireza Javadi to Chief Technical Officer - marketscreener.com

Jan 28, 2026
pulisher
Jan 28, 2026

Rani Therapeutics announces the promotion of Alireza Javadi, Ph.D. to chief technical officer - marketscreener.com

Jan 28, 2026
pulisher
Jan 28, 2026

Rani Therapeutics Names Alireza Javadi Chief Technical Officer - Nasdaq

Jan 28, 2026
pulisher
Jan 28, 2026

Rani Therapeutics promotes Alireza Javadi to chief technical officer - Investing.com

Jan 28, 2026
pulisher
Jan 28, 2026

Rani Therapeutics Announces the Promotion of Alireza Javadi, Ph.D. to Chief Technical Officer - The Manila Times

Jan 28, 2026
pulisher
Jan 28, 2026

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Jan 28, 2026
pulisher
Jan 24, 2026

Bear Alert: Does CompoSecure Inc Equity Warrant stock have upside surprise potential2025 Sector Review & Daily Stock Trend Watchlist - baoquankhu1.vn

Jan 24, 2026
pulisher
Jan 23, 2026

Published on: 2026-01-24 03:15:13 - baoquankhu1.vn

Jan 23, 2026
pulisher
Jan 23, 2026

AI Stocks: Does XBiotech Inc offer margin of safety2025 Macro Impact & Short-Term High Return Ideas - baoquankhu1.vn

Jan 23, 2026
pulisher
Jan 23, 2026

Retail investors account for 65% of Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) ownership, while private equity firms account for 17% - Yahoo Finance

Jan 23, 2026
pulisher
Jan 23, 2026

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Ardelyx (ARDX) and AxoGen (AXGN) - The Globe and Mail

Jan 23, 2026
pulisher
Jan 22, 2026

Analysts Offer Insights on Healthcare Companies: Trevi Therapeutics (TRVI), Artiva Biotherapeutics, Inc. (ARTV) and Oncolytics Biotech (ONCY) - The Globe and Mail

Jan 22, 2026
pulisher
Jan 20, 2026

Rani Therapeutics finalizes governance and capital structure changes - MSN

Jan 20, 2026
pulisher
Jan 19, 2026

Targets Report: Can Rani Therapeutics Holdings Inc navigate macro headwindsJuly 2025 Chart Watch & Consistent Return Investment Signals - baoquankhu1.vn

Jan 19, 2026
pulisher
Jan 12, 2026

Price Action: Can Rani Therapeutics Holdings Inc navigate macro headwinds2025 Technical Patterns & Community Supported Trade Ideas - baoquankhu1.vn

Jan 12, 2026
pulisher
Jan 09, 2026

HOKA Shoe Comparison: Will Rani Therapeutics Holdings Inc. stock outperform tech sector in 2025Grip and Outsole Review & quick comparison of popular models - Улправда

Jan 09, 2026
pulisher
Jan 09, 2026

HC Wainwright Reaffirms Buy Rating for Rani Therapeutics (NASDAQ:RANI) - MarketBeat

Jan 09, 2026
pulisher
Jan 09, 2026

RANI: HC Wainwright Reiterates Buy Rating with $11 Target | RANI Stock News - GuruFocus

Jan 09, 2026
pulisher
Jan 09, 2026

Is Rani Therapeutics Holdings Inc. stock positioned well for digital economyJuly 2025 Summary & Consistent Return Investment Signals - Улправда

Jan 09, 2026
pulisher
Jan 09, 2026

How Rani Therapeutics Holdings Inc. stock reacts to inflationary pressuresTrade Risk Report & Long-Term Investment Growth Plans - Улправда

Jan 09, 2026
pulisher
Jan 09, 2026

How Rani Therapeutics Holdings Inc. stock compares to growth peersJuly 2025 Chart Watch & Verified Momentum Stock Watchlist - Улправда

Jan 09, 2026
pulisher
Jan 09, 2026

Can Rani Therapeutics Holdings Inc. stock sustain revenue growthQuarterly Profit Report & Verified Momentum Stock Alerts - Улправда

Jan 09, 2026
pulisher
Jan 09, 2026

Can Rani Therapeutics Holdings Inc. stock hit record highs againQuarterly Profit Review & Growth Focused Entry Point Reports - Улправда

Jan 09, 2026
pulisher
Jan 08, 2026

Aug Intraday: Is Rani Therapeutics Holdings Inc. stock positioned well for digital economyJuly 2025 Volume & Scalable Portfolio Growth Methods - Улправда

Jan 08, 2026
pulisher
Jan 08, 2026

Rani Therapeutics begins phase 1 trial of oral obesity treatment By Investing.com - Investing.com Australia

Jan 08, 2026
pulisher
Jan 08, 2026

Rani Therapeutics Initiates Phase 1 Study of RT-114 RaniPill® for the Treatment of Obesity in Collaboration with ProGen - The Manila Times

Jan 08, 2026
pulisher
Jan 08, 2026

Rani Therapeutics begins phase 1 trial of oral obesity treatment - Investing.com

Jan 08, 2026
pulisher
Jan 08, 2026

Rani Therapeutics Initiates Phase 1 Study of RT-114 - GlobeNewswire

Jan 08, 2026
pulisher
Jan 07, 2026

Can Rani Therapeutics Holdings Inc. stock rebound after recent weaknessMorning Star Patterns & Invest Now - Улправда

Jan 07, 2026
pulisher
Jan 03, 2026

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jan 03, 2026
pulisher
Jan 03, 2026

Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement - Investing.com Nigeria

Jan 03, 2026
$26.70
price down icon 0.26%
$45.47
price up icon 1.37%
$101.86
price up icon 1.08%
$106.77
price up icon 0.95%
$151.84
price up icon 3.82%
biotechnology ONC
$350.16
price up icon 1.08%
Capitalizzazione:     |  Volume (24 ore):